Study on Gut Microbiota in Chronic HBV Infected Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2020-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hepatitis B Virus(HBV) infection is a common infectious disease affecting up to 2 billion people worldwide. Around 650 thousand people died of liver failure, cirrhosis and primary liver cancer caused by chronic hepatitis B every year. Age is the main factor affecting the chronicity of hepatitis B, while 90% and 25% to 30% of hepatitis b virus(HBV) infection in perinatal and infant period will develop into chronic infection respectively. Whereas the proportion in patients above 5 years old is only 5% to 10%. Intestinal microbiota plays an important role in maintaining nomal physiological function of the intestine and the immune function of the body. It has been found that the disorder of intestinal microbiota is associated with numerous intestinal and parenteral diseases. Recently, the relationship between immune response and intestinal microbiota has been claimed. In a previous study using IMT to treat HBeAg positive chronic hepatits B patients combined with antiviral theraopy, 80% of them has reached HBeAg clearance. Increasing evidence suggests that the gut microbiota has evolved as a new important player in the pathogenesis of hepatitis B virus-induced chronic liver disease. However, the composition and structure alteration of the gut microbiota associated with the stage and progression of HBV infection remains unknown. Hence, we proposed a trial to detected gut microbiota of chronic HBV infected patients high-throughput 16S rRNA gene sequencing to elucidate the microbial influence which contribute to the microbial shift of patient in different stage.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B

NCT05705141

Chronic Hepatitis b

NOT_YET_RECRUITING

Population-wide Research for HBV-related Liver Diseases in Maoming City

NCT06184347

HBV Infection Chronic Hepatitis B Cirrhosis +1 more

NOT_YET_RECRUITING

Observational Study on Patients With Chronic Hepatitis B

NCT02167503

Chronic Hepatitis B

UNKNOWN

"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu

NCT03097952

Hepatitis B， Chronic

RECRUITING

A Comprehensive HBsAg-positive Patients Centered Screening Strategy

NCT03794791

Hepatitis B and Hepatitis C (Disorder)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Hepatitis B Infection Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

1. Alcohol free history or alcohol consumption \<140g per week in male, \<70g per week in female
2. smooth and soft stool like sausage or snake
3. Voluntary participate in this study

Exclusion Criteria

1. Syptom of digestive system disorder such as hematochezia, constipation, Abdominal distention, abdominal pain, diarrhea and jaundice within 1 month
2. Abormal results of several tests including: fecal routine, fecal occult blood test
3. Be diagnosed as enteritis within 1 month
4. Chronic obstructive pulmonary disease, renal insufficiency and other systemic diseases.
5. Autoimmune disease
6. Chronic fatigue syndrome and neuropsychic disease
7. A history of antibiotics, microecological preparation, gastrointestinal motility medicine, laxative, weight loss drug, Glucose lowering, blood fat regulation, glucocorticoid or immunosuppressor treatment within 1 month
8. History of organic diseases in digestive system such as gastrointestinal polyposis, ulcers, malignancies, etc.
9. History of gastrointestinal surgery

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes